STOCK TITAN

Everpure trust proposes roughly $11.4M share sale

The proposed amount is listed at an aggregate market value of approximately $11,366,000, with a Rule 10b5-1 plan date of January 8, 2026.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Everpure, Inc. (P) is named as issuer in a notice that The Colgrove Family Charitable Remainder Trust U/A dated April 5, 2024 proposes to sell 100,000 common shares on approximately September 22, 2026, at an aggregate market value of approximately $11,366,000. The notice lists January 8, 2026 as the Rule 10b5-1 plan adoption or instruction date. It also reports that the trust sold 100,000 shares on September 21, 2026, for gross proceeds of $11,034,990, as part of the listed 10b5-1 sales. The relationship-to-issuer entries are Director and Officer; John A. Colgrove signed the notice.

Proposed shares to be sold 100,000 shares Approximately September 22, 2026
Aggregate market value Approximately $11,366,000 Proposed sale
Shares sold 100,000 shares Colgrove trust sale on September 21, 2026
Gross proceeds $11,034,990 Colgrove trust sale on September 21, 2026
Rule 10b5-1 regulatory
"If Relying on Rule 10b5-1"
Rule 10b5-1 is a regulation that allows company insiders to buy or sell their shares at predetermined times, even if they have access to non-public information. It acts like setting a schedule in advance for transactions, helping prevent accusations of unfair trading. This rule provides a way for insiders to plan trades transparently, giving investors confidence that these transactions are not based on hidden information.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Founders Shares financial
"Nature of Acquisition Transaction: Founders Shares"
Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many Everpure (P) shares does the Colgrove trust propose to sell?

The Colgrove Family Charitable Remainder Trust proposes to sell 100,000 common shares on approximately September 22, 2026. The notice lists an approximate aggregate market value of $11,366,000.

What date is listed for the Everpure (P) Rule 10b5-1 plan?

The notice lists January 8, 2026 as the plan adoption or instruction date for reliance on Rule 10b5-1.

What recent Everpure (P) sale by the Colgrove trust is reported?

The trust's reported sale on September 21, 2026 was 100,000 shares, with gross proceeds of $11,034,990.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading